Chemoinformaics analysis of 9-HYDROXY-4-(3,7-DIMETHYL-2,6-OCTADIENYLOXY)-PSORALEN
Molecular Weight | 368.429 | nRot | 7 |
Heavy Atom Molecular Weight | 344.237 | nRig | 18 |
Exact Molecular Weight | 368.162 | nRing | 3 |
Solubility: LogS | -5.448 | nHRing | 2 |
Solubility: LogP | 6.176 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 3 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 51 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 27 | No. of Aromatic Carbocycles | 1 |
nHetero | 5 | No. of Aromatic Hetero Cycles | 2 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 22 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 13 |
No. of Oxygen atom | 5 | No. of Arom Bond | 15 |
nHA | 5 | APOL | 56.753 |
nHD | 0 | BPOL | 31.889 |
QED | 0.4 |
Synth | 2.974 |
Natural Product Likeliness | 1.882 |
NR-PPAR-gamma | 0.038 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.694 |
Pgp-sub | 0.01 |
HIA | 0.007 |
CACO-2 | -4.696 |
MDCK | 0.0000191 |
BBB | 0.006 |
PPB | 0.745451 |
VDSS | 1.539 |
FU | 0.157737 |
CYP1A2-inh | 0.963 |
CYP1A2-sub | 0.249 |
CYP2c19-inh | 0.96 |
CYP2c19-sub | 0.139 |
CYP2c9-inh | 0.914 |
CYP2c9-sub | 0.825 |
CYP2d6-inh | 0.592 |
CYP2d6-sub | 0.53 |
CYP3a4-inh | 0.619 |
CYP3a4-sub | 0.166 |
CL | 13.907 |
T12 | 0.111 |
hERG | 0.038 |
Ames | 0.162 |
ROA | 0.193 |
SkinSen | 0.172 |
Carcinogencity | 0.734 |
EI | 0.047 |
Respiratory | 0.746 |
NR-Aromatase | 0.826 |
Antiviral | No |
Prediction | 0.521405 |